IPARINTERPARFUMS INC
Health Care
Net Income (Loss) Attributable to Parent revised up 23.5% for FY 2025
This is the 4th largest revision in IPAR's history.
Net Income (Loss) Attributable to Parent·FY 2025
Major restatement$208M▲ 23.5%
was$168.4M
Revised up. Any P/E built on the original was 19.0% too high.
Verify against SEC filingsShow
As reported$168.4M
Accepted 2026-03-100001753926-26-000464
Restated$208M
Accepted 2026-07-310001753926-26-001295
NetIncome · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time IPAR — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.